Lonza Group is a Swiss multinational life sciences company that provides products and services to the pharmaceutical, biotech and specialty ingredients markets. Headquartered in Switzerland, the company operates globally with manufacturing and research facilities across Europe, North America and Asia, serving customers involved in drug discovery, development and commercial production. Lonza's client base ranges from large pharmaceutical firms to emerging biotech companies and manufacturers of consumer health and specialty chemical products.
The company’s core activities center on contract development and manufacturing (CDMO) for small molecules and biologics, including process development, clinical and commercial-scale manufacturing, and fill–finish services. Lonza also supplies a range of life science products such as cell culture media, reagents and tools used in research and development, as well as active pharmaceutical ingredients (APIs), excipients and formulation services. In recent years it has expanded capabilities in advanced therapies, including cell and gene therapy support, viral vector production and related upstream and downstream processing services.
Lonza emphasizes integrated partnerships that span early-stage development through commercial manufacturing, regulatory support and quality assurance to help clients accelerate time to market. Its operations typically combine technical development teams, GMP manufacturing suites and analytical laboratories to provide scalable solutions tailored to client programs. The company’s offerings are positioned to address growing demand for outsourced biomanufacturing, biologics and advanced-therapy production capacity worldwide.
Originally established in Switzerland, Lonza has grown through organic investment and strategic acquisitions to build an international footprint and diversified service portfolio. The company is governed by an executive management team and a board based in Switzerland and operates under global regulatory standards applicable to pharmaceutical and biotech manufacturing. Lonza’s broad service scope and global infrastructure make it a significant contract partner for companies seeking outsourced development and manufacturing expertise in the life sciences sector.
AI Generated. May Contain Errors.
